MiniMed Group, Inc. Common Stock (MMED)vsSimulations Plus Inc (SLP)
MMED
MiniMed Group, Inc. Common Stock
$16.31
-4.62%
HEALTHCARE · Cap: $4.80B
SLP
Simulations Plus Inc
$11.54
-0.26%
HEALTHCARE · Cap: $240.55M
Smart Verdict
WallStSmart Research — data-driven comparison
MiniMed Group, Inc. Common Stock generates 3568% more annual revenue ($2.89B vs $78.68M). MMED leads profitability with a -7.3% profit margin vs -81.7%. SLP earns a higher WallStSmart Score of 40/100 (D).
MMED
Hold37
out of 100
Grade: F
SLP
Hold40
out of 100
Grade: D
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Reasonable price relative to book value
Areas to Watch
0.0% earnings growth
ROE of 0.0% — below average capital efficiency
Operating margin of 1.4%
Negative free cash flow — burning cash
2.0% earnings growth
Smaller company, higher risk/reward
Operating margin of 3.9%
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : MMED
Revenue growth of 13.1% demonstrates continued momentum.
Bull Case : SLP
The strongest argument for SLP centers on Price/Book.
Bear Case : MMED
The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.
Bear Case : SLP
The primary concerns for SLP are EPS Growth, Market Cap, Operating Margin.
Key Dynamics to Monitor
MMED is growing revenue faster at 13.1% — sustainability is the question.
SLP generates stronger free cash flow (4M), providing more financial flexibility.
Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
SLP scores higher overall (40/100 vs 37/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MiniMed Group, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.
Simulations Plus Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling, simulation, and prediction of molecule properties using artificial intelligence and machine learning technology worldwide. The company is headquartered in Lancaster, California.
Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?